Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Triple Negative Breast Neoplasms × sintilimab × Clear all

Phase

Status

Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 21 Stomach Neoplasms 17 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 8 Nasopharyngeal Carcinoma 5 Lung Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Lymphoma, Extranodal NK-T-Cell 3 Cholangiocarcinoma 3 Small Cell Lung Carcinoma 2 Nonsquamous Non-Small Cell Lung Cancer 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Advanced Biliary Tract Cancer 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Thoracic Malignancies 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Respiratory Tract Diseases 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 PD-1 Antibody 1

Interventions

Carboplatin 13 camrelizumab 11 Capecitabine 11 130-nm albumin-bound paclitaxel 9 Paclitaxel 8 pembrolizumab 7 eribulin 7 Cyclophosphamide 7 Gemcitabine 6 Epirubicin 6 apatinib 5 Cisplatin 5 tislelizumab 4 atezolizumab 4 anlotinib 4 Taxes 4 Nivolumab 4 Bevacizumab 4 Vinorelbine 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Doxorubicin 3 Docetaxel 3 toripalimab 2 talazoparib 2 fluzoparib 2 famitinib 2 Zoledronic Acid 2 Metformin 2 Injections 2 IPI-549 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04809779 2021-03-22

NeoPD1TNBC

First Affiliated Hospital, Sun Yat-Sen University

Phase 2 Unknown

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡